Updates on Bintrafusp alfa/M7824 Clinical Data
PharmaTalkRadio7 Mar 2020

Updates on Bintrafusp alfa/M7824 Clinical Data

In this podcast, first recorded at the 4th annual IO Combinations 360° conference, Dr Laureen Ojalvo, EMD Serono provides an overview of the moleculte Bintrafusp alfa/M7824. This molecule is an innovative, first-in-class bifunctional fusion protein composed of an anti-PD-L1 mAb fused with 2 extracellular domains of TGF-βRII (a TGF-β “trap”). The mechanism of action, pre-clinical and phase 1 studies of this molecule is discussed as well as an overview of the next wave of clinical development. To learn more about the upcoming IO Combinations 360° conference please visit, www.iocombinations360.com

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(461)

Populært innen Vitenskap

fastlegen
tingenes-tilstand
romkapsel
rss-nysgjerrige-norge
sinnsyn
forskningno
rekommandert
dekodet-2
liberal-halvtime
rss-paradigmepodden
fjellsportpodden
rss-rekommandert
tidlose-historier
jss
grunnstoffene
villmarksliv
hva-er-greia-med
vett-og-vitenskap-med-gaute-einevoll
nordnorsk-historie
aldring-og-helse-podden